Add BrightSurf on Google Email

Study compares common type 2 diabetes drugs, finding higher cardiovascular risk for one medication

A recent study published in JAMA Network Open found that glipizide, a commonly used type 2 diabetes medication, is associated with a 13% increase in cardiovascular risk compared to dipeptidyl peptidase-4 (DPP-4) inhibitors. The study analyzed data from nearly 50,000 patients and found that glipizide was linked to higher rates of heart ...

SourceMass General Brigham·JournalJAMA Network Open·TypeObservational study·DateJul 24, 2025

Rethink the 10,000 a day step goal, study suggests

A new study published in The Lancet Public Health found that walking 7000 steps a day offers similar health benefits as walking 10,000 steps. The research analyzed data from 57 studies and found significant improvements in eight major health outcomes, including reduced risk of cardiovascular disease, dementia, and depressive symptoms.

SourceUniversity of Sydney·JournalThe Lancet Public Health·TypeSystematic review·DateJul 23, 2025

‘Weekend warriors’ with diabetes have a 33% lower risk of cardiovascular mortality

A prospective cohort study found that weekend warriors and regular activity patterns reduced risks for all-cause and cardiovascular mortality among adults with diabetes, demonstrating the importance of any physical activity. The study also compared GLP-1RAs and DPP4is in dementia risk among older adults with diabetes and found no clear...

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateJul 21, 2025

A new diabetes subtype identified in Sub-Saharan Africa and Black Americans, study finds

Researchers have discovered a non-autoimmune form of type 1 diabetes prevalent in young people in Sub-Saharan Africa, differing from the typical autoimmune pattern seen in other regions. The study's findings also suggest an ancestral or genetic link between this subtype and African ancestry in the US.

SourceUniversity of Colorado Anschutz Medical Campus·JournalThe Lancet Diabetes & Endocrinology·DateJul 21, 2025

Innovative implant delivers sustained hydrogen therapy

Researchers developed a novel nanoconfinement strategy to deliver molecular hydrogen for diabetic bone repair. The innovative implant achieves controlled and sustained H2 release, promoting bone regeneration and neural network formation. This technology addresses key limitations of conventional H2 therapy.

SourceShenzhen Institute of Advanced Technology, Chinese Academy of Sciences·JournalAdvanced Materials·TypeExperimental study·DateJul 18, 2025

Nighttime pistachio snacking may reshape gut microbiome in prediabetic adults

A new study found that consuming pistachios every night for 12 weeks altered bacteria in the gut of adults with prediabetes, increasing beneficial short-chain fatty acids like butyrate. The changes may offer long-term health benefits, potentially slowing Type 2 diabetes development or reducing inflammation.

SourcePenn State·JournalCurrent Developments in Nutrition·TypeRandomized controlled/clinical trial·DateJul 14, 2025

Lonely adults may have a higher risk of diabetes

A study presented at the Endocrine Society's annual meeting found that socially isolated older adults are 34% more likely to have diabetes and 75% more likely to have poor blood sugar control. Social isolation is being recognized as a critical social determinant of health, highlighting its importance in caring for older patients.

Uncovering the relationship between oral function and lifestyle-related diseases

A recent study published by Fujita Health University found that poor oral health can increase the risk of lifestyle-related diseases such as diabetes and heart disease. The researchers examined 118 individuals aged 50 or above and found significant links between oral function test results and blood test results.

SourceFujita Health University·JournalJournal of Oral Rehabilitation·TypeData/statistical analysis·DateJul 10, 2025

Implantable device could save diabetes patients from dangerously low blood sugar

Researchers at MIT developed an implantable device that can store glucagon to counteract hypoglycemia, a life-threatening condition for people with Type 1 diabetes. The device, about the size of a quarter, contains a small reservoir made of 3D-printed polymer and can be triggered remotely or automatically by a sensor.

SourceMassachusetts Institute of Technology·JournalNature Biomedical Engineering·DateJul 9, 2025

‘Inflammatory’ diet during pregnancy may raise child’s diabetes type 1 risk

A study published in the Journal of Epidemiology & Community Health found that a pro-inflammatory diet during pregnancy may raise a child's risk of developing type 1 diabetes. The research, which followed pregnant women from Denmark, found a 16% increase in risk for each unit increase in dietary measure of inflammatory food intake.

SourceBMJ Group·JournalJournal of Epidemiology and Community Health·TypeObservational study·DateJul 1, 2025

New study challenges assumptions about single-food interventions for blood sugar control in persons at risk of type 2 diabetes

A new international study found that replacing regular bread with oat β-glucan-enriched bread did not significantly improve long-term blood sugar control. The CarbHealth study involved nearly 200 participants and aimed to test whether a simple dietary swap could yield measurable health benefits.

SourceThe University of Bergen·JournalClinical Nutrition·DateJun 30, 2025

Emotional demands and confrontation in person-contact roles linked to heightened type 2 diabetes risk

Research published in Occupational & Environmental Medicine found a strong association between working in person-contact roles and an increased risk of developing type 2 diabetes. High levels of emotional demands and confrontation were particularly linked to a higher risk, especially among those with low social support at work.

SourceBMJ Group·JournalOccupational and Environmental Medicine·TypeObservational study·DateJun 24, 2025

Insulin on edge: Study identifies stress-triggered gene behind diabetes

Researchers at Osaka Metropolitan University have identified the REDD2 gene, which is activated by metabolic stress and damages pancreatic β-cells, leading to reduced insulin secretion and the onset of diabetes. Suppressing REDD2 expression protects β-cells from damage, even under stress from overeating, preventing the onset of diabetes.

SourceOsaka Metropolitan University·JournalJournal of Biological Chemistry·TypeExperimental study·DateJun 24, 2025

Weekly semaglutide improves blood sugar and weight in adults with Type 1 diabetes

A new clinical trial found that taking semaglutide once weekly significantly improves blood sugar levels and leads to substantial weight loss in adults with Type 1 diabetes. The study involved 72 participants across four medical centers and showed a 36% improvement rate compared to the placebo group.

SourceOregon Health & Science University·JournalNEJM Evidence·TypeRandomized controlled/clinical trial·DateJun 23, 2025

Living near an ocean polluted by microplastics may increase cardiometabolic disease risk

A new study published in the Journal of the American Heart Association found that residents in U.S. coastal counties near ocean waters with high concentrations of microplastics are at higher risk for Type 2 diabetes, coronary artery disease, and stroke. The study analyzed data from 152 counties and found a significant association betwe...

SourceAmerican Heart Association·JournalJournal of the American Heart Association·DateJun 18, 2025

Tufts chemists design a next generation of weight loss drugs

Researchers at Tufts University have designed a new compound that incorporates structural elements of four hormones - GLP-1, GIP, glucagon, and PYY - to create a single weight loss drug. This chimera peptide aims to address the drawbacks of current weight loss drugs, such as nausea and limited efficacy.

SourceTufts University·JournalJournal of the American Chemical Society·TypeExperimental study·DateJun 10, 2025

Why does diabetes affect brain structure? — Quan Zhang and Feng Liu’s team at Tianjin Medical University General Hospital uncovers the underlying genetic mechanisms

Research reveals shared genetic associations between type 2 diabetes mellitus and subcortical brain volumes, including hippocampus and amygdala. The study identifies 229 loci associated with T2DM and 220 loci with subcortical brain structures, providing critical genetic evidence for risk prediction and early intervention strategies.

SourceResearch·JournalResearch·TypeNews article·DateJun 10, 2025

Interactive artificial pancreas better controls type 1 diabetes using digital twins, study finds

A new study published in npj Digital Medicine found that an interactive artificial pancreas system, using digital twins, improved blood sugar control and reduced hemoglobin A1c levels in type 1 diabetes patients. The system adapts to users' changing bodies and allows them to test changes to the system's parameters in a safe simulation ...

SourceUniversity of Virginia Health System·Journalnpj Digital Medicine·DateJun 10, 2025

Johns Hopkins Medicine study finds eating ‘DASH for diabetes’ lower-sodium diet can produce clinically meaningful reduction in blood pressure for people with type 2 diabetes

A new study finds that a lower-sodium DASH-style diet can produce clinically meaningful reductions in blood pressure for adults with type 2 diabetes. The study, which modified the original DASH diet for people with type 2 diabetes, achieved a 5-point reduction in systolic blood pressure, resulting in lower risks of stroke, cardiovascul...

SourceJohns Hopkins Medicine·JournalJAMA Internal Medicine·DateJun 10, 2025

Intensive weight loss programme improves eating disorder symptoms in people with Type 2 Diabetes at risk of eating disorders, Oxford study finds

A University of Oxford study found that an intensive low-energy diet programme significantly improved eating disorder symptoms in people with type 2 diabetes and excess weight at risk of developing eating disorders. The programme showed benefits persisting six months after completion.

SourceUniversity of Oxford·JournalThe Lancet Psychiatry·DateJun 10, 2025

Primary care clinics can successfully use glucose monitors to help people with diabetes

A new study from the University of Colorado Anschutz Medical Campus shows that primary care clinics can effectively introduce continuous glucose monitors (CGMs) into their practices. The study found that both self-guided and virtual CGM initiation services were successful, regardless of clinic size or diabetes expertise.

Timely initiation of statin therapy for diabetes shown to dramatically reduce risk of heart attack and stroke

A new study from Mass General Brigham found that patients with diabetes who started statin therapy immediately reduced the rate of heart attacks and strokes by one-third compared to those who delayed treatment. The study analyzed data from over 7,000 patients and used artificial intelligence to gather information.

SourceMass General Brigham·JournalJournal of the American Heart Association·TypeData/statistical analysis·DateMay 27, 2025